FDA Announces End of Semaglutide Shortage: What This Means for Weight Loss Patients
For nearly three years, patients looking for semaglutide-based weight reduction and diabetes management drugs have faced ongoing shortages. Semaglutide, the active ingredient of popular drugs such as Wegovy and Ozempic, is in high demand due to its proven effectiveness in weight loss and glycemic control. However, supply chain delays and extraordinary demand caused limited availability, […]
